
Esophageal and Gastrosophageal Junction (GEJ) Cancer 2025 UPDATE
Two Onc Docs
00:00
Key Trials Supporting Neoadjuvant Approaches
They summarize CROSS for chemoradiation and MAGIC/FLOT trials, noting FLOT4 adoption and the 2025 NEJM result favoring FLOT in adenocarcinoma.
Play episode from 08:16
Transcript


